Combining nimorazole, chemotherapy and radiotherapy
AssigneeAFYX Therapeutics A/S
InventorsJens OVERGAARD, Vincent GRÉGOIRE, Claus J. MØLLER-SAN PEDRO
Life of this patent
Estimating the term…
Abstract
The present invention relates to the combined use of nimorazole or a pharmaceutically acceptable salt thereof and chemo-radiotherapy. In particular, it relates to the combined use of nimorazole or a pharmaceutically acceptable salt thereof, chemotherapy and radiotherapy for patients suffering from laryngeal, hypopharyngeal and/or oropharyngeal squamous cell carcinoma (SCC).
Claims29
A method for the treatment of cancer or decreasing the probability of recurrence of cancer for at least 36 months, comprising administering to a patient in need thereof (i) nimorazole or a pharmaceutically acceptable salt thereof, (ii) radiotherapy, and (iii) chemotherapy comprising administration of cisplatin.
The method according to claim, wherein the total amount of cisplatin administered is 50-1000 mg/m2.
The method according to claim, wherein the radiotherapy is for curative treatment of cancer or reirradiation of cancer.
The method according to claim, wherein the radiotherapy comprises 1st line irradiation treatment of cancer with curative intent or 2nd line reirradiation treatment of cancer with curative and/or palliation intent.
Dependencies are inferred from the claim text.